1-20 of 55
Stefano Del Prato
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

β-Cell Function, Incretin Effect, and Glucose Kinetics in Response to a Mixed Meal in Patients With Type 2 Diabetes Treated With Dapagliflozin Plus Saxagliptin

Giuseppe Daniele, Andrea Tura, Alex Brocchi, Alessandro Saba, Beatrice Campi, Veronica Sancho-Bornez, Angela Dardano, Stefano Del Prato
Journal: Diabetes Care
Diabetes Care 2024;47(7):1131–1139
https://doi.org/10.2337/dc23-2051
Published: 23 April 2024
View article titled, β-Cell Function, Incretin Effect, and Glucose Kinetics in Response to a Mixed Meal in Patients With Type 2 Diabetes Treated With Dapagliflozin Plus Saxagliptin
Open the PDF for β-Cell Function, Incretin Effect, and Glucose Kinetics in Response to a Mixed Meal in Patients With Type 2 Diabetes Treated With Dapagliflozin Plus Saxagliptin in another window
Journal Articles

Achieving Normoglycemia With Tirzepatide: Analysis of SURPASS 1–4 Trials

Julio Rosenstock, Luis Vázquez, Stefano Del Prato, Denise Reis Franco, Govinda Weerakkody, Biyue Dai, Laura Fernández Landó, Brandon K. Bergman, Angel Rodríguez
Journal: Diabetes Care
Diabetes Care 2023;46(11):1986–1992
https://doi.org/10.2337/dc23-0872
Published: 06 September 2023
View article titled, Achieving Normoglycemia With Tirzepatide: Analysis of SURPASS 1–4 Trials
Open the PDF for Achieving Normoglycemia With Tirzepatide: Analysis of SURPASS 1–4 Trials in another window
Journal Articles

Distinct Mechanisms Responsible for the Increase in Glucose Production and Ketone Formation Caused by Empagliflozin in T2DM Patients

Siham Abdelgani, Ahmed Khattab, John Adams, Mohamed Abu-Farha, Giuseppe Daniele, Fahd Al-Mulla, Stefano Del Prato, Ralph A. DeFronzo, Muhammad Abdul-Ghani
Journal: Diabetes Care
Diabetes Care 2023;46(5):978–984
https://doi.org/10.2337/dc22-0885
Published: 01 March 2023
View article titled, Distinct Mechanisms Responsible for the Increase in Glucose Production and Ketone Formation Caused by Empagliflozin in T2DM Patients
Open the PDF for Distinct Mechanisms Responsible for the Increase in Glucose Production and Ketone Formation Caused by Empagliflozin in T2DM Patients in another window
Journal Articles

Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Melanie J. Davies, Vanita R. Aroda, Billy S. Collins, Robert A. Gabbay, Jennifer Green, Nisa M. Maruthur, Sylvia E. Rosas, Stefano Del Prato, Chantal Mathieu, Geltrude Mingrone, Peter Rossing, Tsvetalina Tankova, Apostolos Tsapas, John B. Buse
Journal: Diabetes Care
Diabetes Care 2022;45(11):2753–2786
https://doi.org/10.2337/dci22-0034
Published: 28 September 2022
View article titled, Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Open the PDF for Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) in another window
Journal Articles

COVID-19, Hyperglycemia, and New-Onset Diabetes

Kamlesh Khunti, Stefano Del Prato, Chantal Mathieu, Steven E. Kahn, Robert A. Gabbay, John B. Buse
Journal: Diabetes Care
Diabetes Care 2021;44(12):2645–2655
https://doi.org/10.2337/dc21-1318
Published: 08 October 2021
View article titled, COVID-19, Hyperglycemia, and New-Onset Diabetes
Open the PDF for COVID-19, Hyperglycemia, and New-Onset Diabetes in another window
Journal Articles

Erratum. Accuracy of 1-Hour Plasma Glucose During the Oral Glucose Tolerance Test in Diagnosis of Type 2 Diabetes in Adults: A Meta-analysis. Diabetes Care 2021;44: 1062–1069

Vasudha Ahuja, Pasi Aronen, T.A. Pramodkumar, Helen Looker, Angela Chetrit, Aini H. Bloigu, Auni Juutilainen, Cristina Bianchi, Lucia La Sala, Ranjit Mohan Anjana, Rajendra Pradeepa, Ulagamadesan Venkatesan, Sarvanan Jebarani, Viswanathan Baskar, Teresa Vanessa Fiorentino, Patrick Timpel, Ralph A. DeFronzo, Antonio Ceriello, Stefano Del Prato, Muhammad Abdul-Ghani, Sirkka Keinänen-Kiukaanniemi, Rachel Dankner, Peter H. Bennett, William C. Knowler, Peter Schwarz, Giorgio Sesti, Rie Oka, Viswanathan Mohan, Leif Groop, Jaakko Tuomilehto, Samuli Ripatti, Michael Bergman, Tiinamaija Tuomi
Journal: Diabetes Care
Diabetes Care 2021;44(6):1457
https://doi.org/10.2337/dc21-er06c
Published: 18 June 2021
View article titled, Erratum. Accuracy of 1-Hour Plasma Glucose During the Oral Glucose Tolerance Test in Diagnosis of Type 2 Diabetes in Adults: A Meta-analysis. Diabetes Care 2021;44: 1062–1069
Open the PDF for Erratum. Accuracy of 1-Hour Plasma Glucose During the Oral Glucose Tolerance Test in Diagnosis of Type 2 Diabetes in Adults: A Meta-analysis. Diabetes Care 2021;44: 1062–1069 in another window
Journal Articles

Response to Comment on Garofolo et al. Insulin Resistance and Risk of Major Vascular Events and All-Cause Mortality in Type 1 Diabetes: A 10-Year Follow-up Study. Diabetes Care 2020;43:e139–e141

Monia Garofolo, Elisa Gualdani, Cristina Bianchi, Michele Aragona, Fabrizio Campi, Daniela Lucchesi, Giuseppe Daniele, Roberto Miccoli, Paolo Francesconi, Stefano Del Prato, Giuseppe Penno
Journal: Diabetes Care
Diabetes Care 2021;44(4):e81
https://doi.org/10.2337/dci20-0079
Published: 15 March 2021
View article titled, Response to Comment on Garofolo et al. Insulin Resistance and Risk of Major Vascular Events and All-Cause Mortality in Type 1 Diabetes: A 10-Year Follow-up Study. Diabetes Care 2020;43:e139–e141
Open the PDF for Response to Comment on Garofolo et al. Insulin Resistance and Risk of Major Vascular Events and All-Cause Mortality in Type 1 Diabetes: A 10-Year Follow-up Study. Diabetes Care 2020;43:e139–e141 in another window
Journal Articles

Accuracy of 1-Hour Plasma Glucose During the Oral Glucose Tolerance Test in Diagnosis of Type 2 Diabetes in Adults: A Meta-analysis

Vasudha Ahuja, Pasi Aronen, T.A. Pramodkumar, Helen Looker, Angela Chetrit, Aini H. Bloigu, Auni Juutilainen, Cristina Bianchi, Lucia La Sala, Ranjit Mohan Anjana, Rajendra Pradeepa, Ulagamadesan Venkatesan, Sarvanan Jebarani, Viswanathan Baskar, Teresa Vanessa Fiorentino, Patrick Timpel, Ralph A. DeFronzo, Antonio Ceriello, Stefano Del Prato, Muhammad Abdul-Ghani, Sirkka Keinänen-Kiukaanniemi, Rachel Dankner, Peter H. Bennett, William C. Knowler, Peter Schwarz, Giorgio Sesti, Rie Oka, Viswanathan Mohan, Leif Groop, Jaakko Tuomilehto, Samuli Ripatti, Michael Bergman, Tiinamaija Tuomi
Journal: Diabetes Care
Diabetes Care 2021;44(4):1062–1069
https://doi.org/10.2337/dc20-1688
Published: 15 March 2021
View article titled, Accuracy of 1-Hour Plasma Glucose During the Oral Glucose Tolerance Test in Diagnosis of Type 2 Diabetes in Adults: A Meta-analysis
Open the PDF for Accuracy of 1-Hour Plasma Glucose During the Oral Glucose Tolerance Test in Diagnosis of Type 2 Diabetes in Adults: A Meta-analysis in another window
Journal Articles

Metformin Benefits: Another Example for Alternative Energy Substrate Mechanism?

Andrea Giaccari, Anna Solini, Simona Frontoni, Stefano Del Prato
Journal: Diabetes Care
Diabetes Care 2021;44(3):647–654
https://doi.org/10.2337/dc20-1964
Published: 11 February 2021
View article titled, Metformin Benefits: Another Example for Alternative Energy Substrate Mechanism?
Open the PDF for Metformin Benefits: Another Example for Alternative Energy Substrate Mechanism? in another window
Journal Articles

Durable Effects of iGlarLixi Up to 52 Weeks in Type 2 Diabetes: The LixiLan-G Extension Study

Lawrence Blonde, Julio Rosenstock, Juan Frias, Andreas L. Birkenfeld, Elisabeth Niemoeller, Elisabeth Souhami, Chen Ji, Stefano Del Prato, Vanita R. Aroda
Journal: Diabetes Care
Diabetes Care 2021;44(3):774–780
https://doi.org/10.2337/dc20-2023
Published: 19 January 2021
View article titled, Durable Effects of iGlarLixi Up to 52 Weeks in Type 2 Diabetes: The LixiLan-G Extension Study
Open the PDF for Durable Effects of iGlarLixi Up to 52 Weeks in Type 2 Diabetes: The LixiLan-G Extension Study in another window
Journal Articles

Reinterpreting Cardiorenal Protection of Renal Sodium–Glucose Cotransporter 2 Inhibitors via Cellular Life History Programming

Angelo Avogaro, Gian Paolo Fadini, Stefano Del Prato
Journal: Diabetes Care
Diabetes Care 2020;43(3):501–507
https://doi.org/10.2337/dc19-1410
Published: 16 December 2020
View article titled, Reinterpreting Cardiorenal Protection of Renal Sodium–Glucose Cotransporter 2 Inhibitors via Cellular Life History Programming
Open the PDF for Reinterpreting Cardiorenal Protection of Renal Sodium–Glucose Cotransporter 2 Inhibitors via Cellular Life History Programming in another window
Journal Articles

Insulin Resistance and Risk of Major Vascular Events and All-Cause Mortality in Type 1 Diabetes: A 10-Year Follow-up Study

Monia Garofolo, Elisa Gualdani, Maria Giovanna Scarale, Cristina Bianchi, Michele Aragona, Fabrizio Campi, Daniela Lucchesi, Giuseppe Daniele, Roberto Miccoli, Paolo Francesconi, Stefano Del Prato, Giuseppe Penno
Journal: Diabetes Care
Diabetes Care 2020;43(10):e139–e141
https://doi.org/10.2337/dc20-0433
Published: 13 August 2020
View article titled, Insulin Resistance and Risk of Major Vascular Events and All-Cause Mortality in Type 1 Diabetes: A 10-Year Follow-up Study
Open the PDF for Insulin Resistance and Risk of Major Vascular Events and All-Cause Mortality in Type 1 Diabetes: A 10-Year Follow-up Study in another window
Journal Articles

Hyperglycemia at Hospital Admission Is Associated With Severity of the Prognosis in Patients Hospitalized for COVID-19: The Pisa COVID-19 Study

Alberto Coppelli, Rosa Giannarelli, Michele Aragona, Giuseppe Penno, Marco Falcone, Giusy Tiseo, Lorenzo Ghiadoni, Greta Barbieri, Fabio Monzani, Agostino Virdis, Francesco Menichetti, Stefano Del Prato, Pisa COVID-19 Study Group, Agostini o Degl’Innocenti Sabrina, Antognoli Rachele, Baldassarri Rubia, Bertini Pietro, Biancalana Martina, Borselli Matteo, Brizzi Giulia, Calsolario Valeria, Carrozzi Laura, Celi Alessandro, Cinotti Francesco, Cipriano Alessandro, Corradi Francesco, De Marco Salvatore, Della Rocca Alessandra, Forfori Francesco, Forotti Giovanna, Galfo Valentina, Guarracino Fabio, Malacarne Paolo, Masi Stefano, Mengozzi Alessandro, Monfroni Marco, Morea Alessandra, Nencini Elia, Park Naria, Paterni Simone, Piagnani Chiara, Ruberti Francesca, Santini Massimo, Sciuto Maria, Spinelli Stefano
Journal: Diabetes Care
Diabetes Care 2020;43(10):2345–2348
https://doi.org/10.2337/dc20-1380
Published: 11 August 2020
View article titled, Hyperglycemia at Hospital Admission Is Associated With Severity of the Prognosis in Patients Hospitalized for COVID-19: The Pisa COVID-19 Study
Open the PDF for Hyperglycemia at Hospital Admission Is Associated With Severity of the Prognosis in Patients Hospitalized for COVID-19: The Pisa COVID-19 Study in another window
Journal Articles

Diabetes and COVID-19: Risks, Management, and Learnings From Other National Disasters

Jamie Hartmann-Boyce, Elizabeth Morris, Clare Goyder, Jade Kinton, James Perring, David Nunan, Kamal Mahtani, John B. Buse, Stefano Del Prato, Linong Ji, Ronan Roussel, Kamlesh Khunti
Journal: Diabetes Care
Diabetes Care 2020;43(8):1695–1703
https://doi.org/10.2337/dc20-1192
Published: 16 June 2020
View article titled, Diabetes and COVID-19: Risks, Management, and Learnings From Other National Disasters
Open the PDF for Diabetes and COVID-19: Risks, Management, and Learnings From Other National Disasters in another window
Journal Articles

Switching to iGlarLixi Versus Continuing Daily or Weekly GLP-1 RA in Type 2 Diabetes Inadequately Controlled by GLP-1 RA and Oral Antihyperglycemic Therapy: The LixiLan-G Randomized Clinical Trial

Lawrence Blonde, Julio Rosenstock, Stefano Del Prato, Robert Henry, Naim Shehadeh, Juan Frias, Elisabeth Niemoeller, Elisabeth Souhami, Chen Ji, Vanita R. Aroda
Journal: Diabetes Care
Diabetes Care 2019;42(11):2108–2116
https://doi.org/10.2337/dc19-1357
Published: 17 September 2019
View article titled, Switching to iGlarLixi Versus Continuing Daily or Weekly GLP-1 RA in Type 2 Diabetes Inadequately Controlled by GLP-1 RA and Oral Antihyperglycemic Therapy: The LixiLan-G Randomized Clinical Trial
Open the PDF for Switching to iGlarLixi Versus Continuing Daily or Weekly GLP-1 RA in Type 2 Diabetes Inadequately Controlled by GLP-1 RA and Oral Antihyperglycemic Therapy: The LixiLan-G Randomized Clinical Trial in another window
Includes: Supplementary data
Journal Articles

Erratum. Cardiovascular Disease and Type 2 Diabetes: Has the Dawn of a New Era Arrived? Diabetes Care 2017;40: 813–820

Muhammad Abdul-Ghani, Ralph A. DeFronzo, Stefano Del Prato, Robert Chilton, Rajvir Singh, Robert E.J. Ryder
Journal: Diabetes Care
Diabetes Care 2017;40(11):1606
https://doi.org/10.2337/dc17-er11
Published: 08 September 2017
View article titled, Erratum. Cardiovascular Disease and Type 2 Diabetes: Has the Dawn of a New Era Arrived? Diabetes Care 2017;40: 813–820
Open the PDF for Erratum. Cardiovascular Disease and Type 2 Diabetes: Has the Dawn of a New Era Arrived? Diabetes Care 2017;40: 813–820 in another window
Journal Articles

Cardiovascular Disease and Type 2 Diabetes: Has the Dawn of a New Era Arrived?

Muhammad Abdul-Ghani, Ralph A. DeFronzo, Stefano Del Prato, Robert Chilton, Rajvir Singh, Robert E.J. Ryder
Journal: Diabetes Care
Diabetes Care 2017;40(7):813–820
https://doi.org/10.2337/dc16-2736
Published: 13 June 2017
View article titled, Cardiovascular Disease and Type 2 Diabetes: Has the Dawn of a New Era Arrived?
Open the PDF for Cardiovascular Disease and Type 2 Diabetes: Has the Dawn of a New Era Arrived? in another window
Includes: Supplementary data
Journal Articles

Introduction to the 5th World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy)

Itamar Raz, William T. Cefalu, Hasan Ilkova, Stefano Del Prato
Journal: Diabetes Care
Diabetes Care 2016;39(Supplement_2):S113–S114
https://doi.org/10.2337/dcS15-3030
Published: 16 July 2016
View article titled, Introduction to the 5th World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy)
Open the PDF for Introduction to the 5th World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy) in another window
Journal Articles

Personalized Therapy by Phenotype and Genotype

Valeriya Lyssenko, Cristina Bianchi, Stefano Del Prato
Journal: Diabetes Care
Diabetes Care 2016;39(Supplement_2):S127–S136
https://doi.org/10.2337/dcS15-3002
Published: 16 July 2016
View article titled, Personalized Therapy by Phenotype and Genotype
Open the PDF for Personalized Therapy by Phenotype and Genotype in another window
Journal Articles

Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations

Francesco Rubino, David M. Nathan, Robert H. Eckel, Philip R. Schauer, K. George M.M. Alberti, Paul Z. Zimmet, Stefano Del Prato, Linong Ji, Shaukat M. Sadikot, William H. Herman, Stephanie A. Amiel, Lee M. Kaplan, Gaspar Taroncher-Oldenburg, David E. Cummings, Delegates of the 2nd Diabetes Surgery Summit, Nizar Albache, Rachel L. Batterham, Deepak L. Bhatt, Camilo Boza, William T. Cefalu, Ricardo V. Cohen, Anita P. Courcoulas, Sean F. Dinneen, John B. Dixon, Ele Ferrannini, Paola Fioretto, Gema Frühbeck, Michel Gagner, Richard W. Grant, Sayeed Ikramuddin, Desmond G. Johnston, Sangeeta R. Kashyap, Tracy Kelly, Tomasz Klupa, Judith Korner, Blandine Laferrère, Harold E. Lebovitz, Wei-Jei Lee, Carel W. le Roux, Jeffrey I. Mechanick, Geltrude Mingrone, John M. Morton, Walter J. Pories, Robert E. Ratner, Gerry Rayman, Harvey J. Sugerman, Luc Van Gaal, Josep Vidal, Jianping Weng, Bruce M. Wolfe
Journal: Diabetes Care
Diabetes Care 2016;39(6):861–877
https://doi.org/10.2337/dc16-0236
Published: 13 May 2016
View article titled, Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations
Open the PDF for Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations in another window
Includes: Supplementary data